Paper41598535
Gut-Heart Axis and Infective Endocarditis: How Microbiota Dysbiosis Shapes Cardiovascular Risk and Infection Susceptibility.
Moffa L and 7 others. J Clin Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Gut-Heart Axis and Infective Endocarditis: How Microbiota Dysbiosis Shapes Cardiovascular Risk and Infection Susceptibility. Papers, record 41598535. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41598535
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gut-Heart Axis and Infective Endocarditis: How Microbiota Dysbiosis Shapes Cardiovascular Risk and Infection Susceptibility.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38732161 | The Mediterranean Diet, Its Microbiome Connections, and Cardiovascular Health: A Narrative Review. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38732161 | PubMed |
| 2 | 38298894 | Gut microbiota and risk of endocarditis: a bidirectional Mendelian randomization study. | Front Microbiol | 2024 | https://conductscience.org/library/papers/38298894 | PubMed |
| 3 | 41296390 | Cellular and Molecular Pathways in Diabetes-Associated Heart Failure: Emerging Mechanistic Insights and Therapeutic Opportunities. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41296390 | PubMed |
| 4 | 37505311 | Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. | Intern Emerg Med | 2024 | https://conductscience.org/library/papers/37505311 | PubMed |
| 5 | 35163143 | Biological Effects of Indole-3-Propionic Acid, a Gut Microbiota-Derived Metabolite, and Its Precursor Tryptophan in Mammals' Health and Disease. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163143 | PubMed |
| 6 | 39794340 | The oral-gut microbiota axis: a link in cardiometabolic diseases. | NPJ Biofilms Microbiomes | 2025 | https://conductscience.org/library/papers/39794340 | PubMed |
| 7 | 28898207 | Shotgun metagenomics, from sampling to analysis. | Nat Biotechnol | 2017 | https://conductscience.org/library/papers/28898207 | PubMed |
| 8 | 40741383 | Emerging therapy targets to modulate microbiome-mediated effects evident in cardiovascular disease. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40741383 | PubMed |
| 9 | 33178196 | Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes. | Front Immunol | 2020 | https://conductscience.org/library/papers/33178196 | PubMed |
| 10 | 39621250 | Gut Microbiota Dysbiosis Facilitates Susceptibility to Bloodstream Infection. | J Microbiol | 2024 | https://conductscience.org/library/papers/39621250 | PubMed |
| 11 | 40403109 | Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure. | Circ Res | 2025 | https://conductscience.org/library/papers/40403109 | PubMed |
| 12 | 36740850 | Bile acids as modulators of gut microbiota composition and function. | Gut Microbes | 2023 | https://conductscience.org/library/papers/36740850 | PubMed |
| 13 | 40299538 | Gut Microbiota in Heart Failure-The Role of Inflammation. | Biomedicines | 2025 | https://conductscience.org/library/papers/40299538 | PubMed |
| 14 | 41096918 | Healthcare-Associated Infections (HAIs) in the Elderly: Molecular Mechanisms of Immunosenescence and Clinical, Nutritional and Therapeutic Implications. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096918 | PubMed |
| 15 | 38181288 | Relationship between trimethylamine N-oxide and the risk of hypertension in patients with cardiovascular disease: A meta-analysis and dose-response relationship analysis. | Medicine (Baltimore) | 2024 | https://conductscience.org/library/papers/38181288 | PubMed |
| 16 | 31517330 | Diverticular Disease: a Gut Microbiota Perspective. | J Gastrointestin Liver Dis | 2019 | https://conductscience.org/library/papers/31517330 | PubMed |
| 17 | 39596530 | The Gut-Heart Axis: Molecular Perspectives and Implications for Myocardial Infarction. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596530 | PubMed |
| 18 | 39997695 | Synergistic Effects of Probiotics and Lifestyle Interventions on Intestinal Microbiota Composition and Clinical Outcomes in Obese Adults. | Metabolites | 2025 | https://conductscience.org/library/papers/39997695 | PubMed |
| 19 | 35807835 | Gut Microbiota-Derived Metabolites and Cardiovascular Disease Risk: A Systematic Review of Prospective Cohort Studies. | Nutrients | 2022 | https://conductscience.org/library/papers/35807835 | PubMed |
| 20 | 32372967 | Protective Effects of Short-Chain Fatty Acids on Endothelial Dysfunction Induced by Angiotensin II. | Front Physiol | 2020 | https://conductscience.org/library/papers/32372967 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41598535
GET https://conductscience.org/api/papers/v1/41598535/references?page=2